Title |
NCCN Guidelines Updates: Management of Prostate Cancer.
|
---|---|
Published in |
Journal of the National Comprehensive Cancer Network (JNCCN), May 2019
|
DOI | 10.6004/jnccn.2019.5011 |
Pubmed ID | |
Authors |
James L Mohler, Emmanuel S Antonarakis |
Abstract |
Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 69 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 12% |
Researcher | 7 | 10% |
Student > Bachelor | 7 | 10% |
Student > Doctoral Student | 5 | 7% |
Other | 5 | 7% |
Other | 8 | 12% |
Unknown | 29 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 35% |
Biochemistry, Genetics and Molecular Biology | 6 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
Unspecified | 1 | 1% |
Nursing and Health Professions | 1 | 1% |
Other | 6 | 9% |
Unknown | 30 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2019.
All research outputs
#22,767,715
of 25,385,509 outputs
Outputs from Journal of the National Comprehensive Cancer Network (JNCCN)
#1,624
of 1,733 outputs
Outputs of similar age
#315,599
of 363,254 outputs
Outputs of similar age from Journal of the National Comprehensive Cancer Network (JNCCN)
#44
of 50 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,733 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.